Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic ...

Beacon Therapeutics reveals promising interim results for laru-zova, a gene therapy showing potential to improve vision in ...

Machine learning algorithms enhance retinopathy of prematurity screening using smartphone images, expanding access in ...

Mark Loganoff, MD, shared his experience and perspective on the benefits and realities of transitioning to office-based surgery in an interview with the Eye Care Network at the 2025 American Society ...

A one-drop, low dose atropine study assesses accommodative amplitude and dynamics, with clinically applicable findings.

Topcon Healthcare launches IDHea, an innovative platform enhancing AI research and ocular data access to improve clinical ...

A study reveals that repeated anti-VEGF injections for AMD do not alter retinal vascular metrics over time, ensuring treatment stability.

Katherine Talcott, MD, a retina specialist at Cleveland Clinic, presented findings on EYP-1901 in the phase 2 DAVIO study.

At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, the Eye Care Network caught up with Jogin Desai. Dr. Desai is the founder of Eyestem Research, a biotechnology ...

In this Q&A, Luke Lindsell, OD, MD, shares his insights on emerging therapies in retina, the evolving role of optometrists in retinal disease management, and the importance of comanagement in patient ...

ASCRS, reveals insights on physician-industry relationships, mentorship opportunities, and the practical applications of AI ...

UNITY Biotechnology reveals promising 36-week results for UBX1325 in treating diabetic macular edema, showing non-inferiority ...